Citation 33793

HSIEH,MT: YEH,FT: CHEN,HC: LIN,NN: CHEN,CF: WANG,TF:. (1988). EFFECTS OF PAWEIWAN ON STREPTOZOTOCIN-INDUCED HYPERGLYCEMIA IN RATS.. 12(2)

Citation Details

Title	EFFECTS OF PAWEIWAN ON STREPTOZOTOCIN-INDUCED HYPERGLYCEMIA IN RATS.
Authors	HSIEH,MT: YEH,FT: CHEN,HC: LIN,NN: CHEN,CF: WANG,TF:
Year	1988
Volume	12
Issue	2

Summary

Year: 1988

Journal: Unknown

Organisms and Their Experiments (8)

Rehmannia glutinosa (SCROPHULARIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Cornus officinalis (CORNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Dioscorea batatas (DIOSCOREACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Paeonia moutan (PAEONIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Alisma species (ALISMATACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Poria cocos (POLYPORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Anemarrhena species (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Phellodendron amurense (RUTACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLYCOGEN CONTENT DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
14	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE

Show SPARQL Queries (1)